HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.

Abstract
IL-6/STAT-3 signals play key roles in inflammatory bowel disease (IBD). It is known that Lactobacillus casei strain Shirota (LcS) improves inflammatory disorders. This study aimed to elucidate the effect of LcS on murine chronic IBD and to clarify the mechanism. We focused the inhibitory effect of LcS on the production of IL-6 in lipopolysaccharide (LPS)-stimulated large intestinal lamina propria mononuclear cells (LI-LPMC) isolated from mice with chronic colitis and in RAW264.7 cells in vitro. We also determined in vivo the effect of LcS on murine chronic IBD models induced with dextran sodium sulphate and SAMP1/Yit mice. Finally, we examined the cellular determinants of LcS for the down-regulation of IL-6 secretion by LI-LPMC, RAW264.7 cells and peripheral blood mononuclear cells (PBMC) derived from patients with ulcerative colitis (UC). LcS, but not other strains of Lactobacillus, inhibited the production of IL-6 in LPS-stimulated LI-LPMC and RAW264.7 cells, down-regulating the nuclear translocation of NF-kappaB. The LcS-diet-improved murine chronic colitis is associated with the reduction of IL-6 synthesis by LI-LPMC. LcS also improved chronic ileitis in SAMP1/Yit mice. The release of IL-6 in vitro in LPS-stimulated LI-LPMC, RAW 264.7 cells and UC-PBMC was inhibited by a polysaccharide-peptidoglycan complex (PSPG) derived from LcS. This probiotic-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines such as IL-6 and IFN-gamma production in LPMC. Therefore, LcS may be a useful probiotic for the treatment of human inflammatory bowel disease.
AuthorsS Matsumoto, T Hara, T Hori, K Mitsuyama, M Nagaoka, N Tomiyasu, A Suzuki, M Sata
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 140 Issue 3 Pg. 417-26 (Jun 2005) ISSN: 0009-9104 [Print] England
PMID15932502 (Publication Type: Journal Article)
Chemical References
  • Interleukin-6
  • Membrane Glycoproteins
  • NF-kappa B
  • Peptidoglycan
  • Receptors, Cell Surface
  • Toll-Like Receptors
  • Interleukin-4
  • Interferon-gamma
Topics
  • Animals
  • Cells, Cultured
  • Chronic Disease
  • Colitis, Ulcerative (immunology)
  • Down-Regulation (immunology)
  • Female
  • Flow Cytometry (methods)
  • Humans
  • Ileitis (immunology)
  • Interferon-gamma (immunology)
  • Interleukin-4 (immunology)
  • Interleukin-6 (immunology)
  • Lactobacillus casei (immunology)
  • Leukocytes, Mononuclear (immunology)
  • Membrane Glycoproteins (immunology)
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (immunology)
  • Peptidoglycan (immunology)
  • Probiotics
  • Receptors, Cell Surface (immunology)
  • Toll-Like Receptors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: